International Clinical Trial: A prospective, multicenter, single-arm clinical study evaluating the efficacy and safety of the TricValve(R) transcatheter implanted double-chamber venous valve system for severe tricuspid regurgitation

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115455) titled 'A prospective, multicenter, single-arm clinical study evaluating the efficacy and safety of the TricValve(R) transcatheter implanted double-chamber venous valve system for severe tricuspid regurgitation' on Dec. 26, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhongshan Hospital, Fudan University

Condition: Significantly hemodynamically significant tricuspid regurgitation (TR) and venous return

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-04-19

Target Sample Size: Experimental group:130;

Countries of Recruitment: China

To know more, vi...